US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Elicio Therapeutics

1.91

-0.0100-0.52%

Volume:120.68K

Turnover:228.54K

Market Cap:50.20M

PE:-0.88

High:1.97

Open:1.96

Low:1.85

Close:1.92

52wk High:16.00

52wk Low:1.71

Shares:26.28M

Float Shares:19.19M

Volume Ratio:0.59

T/O Rate:0.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1721

EPS(LYR):-2.5842

ROE:-774.56%

ROA:-77.88%

PB:6.32

PE(LYR):-0.74

Loading ...

Overview Company News Filings

Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer

THOMSON REUTERS

SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge

Elicio Therapeutics Cut to Hold From Buy by Jones Trading

Elicio Therapeutics downgraded to Hold from Buy at JonesResearch

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

Top Midday Decliners

MT Newswires Live

Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal

Elicio selloff brings attractive entry point, says H.C. Wainwright

Elicio Unveils Phase 2 ELI-002 Results and Phase 3 Plan

Elicio Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Elicio Therapeutics Shares Fall After Missing Primary Endpoint in Pancreatic Cancer Trial

MT Newswires Live

Elicio Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $23 From $17

THOMSON REUTERS

Elicio Therapeutics Shares Fall 50% Premarket After Co Reports Mid-Stage Data for Its Experimental Pancreatic Cancer Therapy

THOMSON REUTERS

BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial

Elicio says Phase 2 AMPLIFY-7P trial of ELI-002 7P misses primary DFS endpoint in adjuvant pancreatic cancer

Elicio Therapeutics - Eli-2 7P Demonstrates Favorable Safety and Tolerability Profile

THOMSON REUTERS

Elicio Therapeutics Reports Results From Phase 2 Amplify-7P Study and Outlines Refined Phase 3 Development Strategy for Eli-002 7P in Adjuvant Pancreatic Cancer

THOMSON REUTERS

Elicio Therapeutics - Evaluating Strategic Financing and Partnering Opportunities

THOMSON REUTERS

Elicio Therapeutics - to Focus Phase 3 Development on R0 Resected Population With Additional Eli-2 7P Dosing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/ELTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ELTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":1.91,"timestamp":1790964353082,"preClose":1.92,"halted":0,"volume":120679,"delay":0,"changeRate":-0.005208333333333338,"floatShares":19192300,"shares":26281900,"eps":-2.172087,"marketStatus":"Trading","change":-0.01,"latestTime":"10-02 14:07:42 EDT","open":1.96,"high":1.97,"low":1.85,"amount":228544.6175454,"amplitude":0.0625,"askPrice":1.91,"askSize":756,"bidPrice":1.89,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":-2.172087,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":1.92,"preHourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.92,"latestTime":"09:28 EDT","volume":1869,"amount":3620.120301,"timestamp":1790947690125,"change":0.02,"changeRate":0.010417,"amplitude":0.04724},"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.92,"latestTime":"19:30 EDT","volume":2278,"amount":4441.19,"timestamp":1790897405106,"change":0.06,"changeRate":0.03125,"amplitude":0.03125},"volumeRatio":0.593949,"impliedVol":1.6643,"impliedVolPercentile":0.4861},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","floatShares":19192300,"roa":"-77.88%","roe":"-774.56%","lyrEps":-2.584186,"volumeRatio":0.593949,"shares":26281900,"dividePrice":0,"high":1.97,"amplitude":0.0625,"preClose":1.92,"low":1.85,"week52Low":1.705,"pbRate":"6.32","week52High":16,"institutionHeld":0,"latestPrice":1.91,"committee":0.264591,"eps":-2.172087,"divideRate":0,"volume":120679,"delay":0,"ttmEps":-2.172087,"open":1.96,"prevYearClose":7.96,"prevWeekClose":1.84,"prevMonthClose":1.82,"prevQuarterClose":1.82,"fiveDayClose":1.84,"twentyDayClose":2.5,"sixtyDayClose":3.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ELTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.53,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2026-05-11","symbol":"ELTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-03-12","symbol":"ELTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-13","symbol":"ELTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-08-07","symbol":"ELTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.69,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELTX","date":"2026-10-01","current":-0.879339,"percent":0.872611,"low":-9.235249,"twenty":-3.168399,"median":-2.173997,"eighty":-1.394238,"high":-0.963611,"avg":-2.481612,"sd":1.269668,"marketCap":47833025},"quantilePoints":[{"date":"2023-06-09","current":-9.235249,"twenty":-9.235249,"median":-9.19865,"eighty":-8.861936,"marketCap":260505032},{"date":"2023-06-16","current":-4.797096,"twenty":-9.19133,"median":-5.471097,"eighty":-5.286091,"marketCap":135315000},{"date":"2023-06-23","current":-3.669177,"twenty":-9.011993,"median":-5.35246,"eighty":-4.343178,"marketCap":103499000},{"date":"2023-06-30","current":-3.232452,"twenty":-8.711878,"median":-5.281964,"eighty":-3.931212,"marketCap":91180000},{"date":"2023-07-07","current":-3.782657,"twenty":-7.82363,"median":-4.797096,"eighty":-3.594899,"marketCap":106700000},{"date":"2023-07-14","current":-3.799851,"twenty":-5.457342,"median":-4.009616,"eighty":-3.669177,"marketCap":107185000},{"date":"2023-07-21","current":-3.868626,"twenty":-5.416077,"median":-3.868626,"eighty":-3.616907,"marketCap":109125000},{"date":"2023-07-28","current":-3.026831,"twenty":-5.342487,"median":-3.782657,"eighty":-3.314983,"marketCap":85379914},{"date":"2023-08-04","current":-2.958445,"twenty":-5.286091,"median":-3.758585,"eighty":-2.99472,"marketCap":83450898},{"date":"2023-08-11","current":-2.973312,"twenty":-5.075638,"median":-3.643386,"eighty":-2.969744,"marketCap":83870250},{"date":"2023-08-18","current":-2.842099,"twenty":-4.570137,"median":-3.57633,"eighty":-2.953093,"marketCap":83656289},{"date":"2023-08-25","current":-2.726636,"twenty":-4.18018,"median":-3.222136,"eighty":-2.868421,"marketCap":79553028},{"date":"2023-09-01","current":-2.370739,"twenty":-4.067388,"median":-3.000071,"eighty":-2.849368,"marketCap":69169264},{"date":"2023-09-07","current":-2.433882,"twenty":-3.951844,"median":-2.973312,"eighty":-2.844375,"marketCap":71011545},{"date":"2023-09-15","current":-2.413791,"twenty":-3.886508,"median":-2.973312,"eighty":-2.761879,"marketCap":70425365},{"date":"2023-09-22","current":-2.293245,"twenty":-3.841116,"median":-2.967365,"eighty":-2.647421,"marketCap":66908283},{"date":"2023-09-29","current":-2.413791,"twenty":-3.792973,"median":-2.953985,"eighty":-2.537207,"marketCap":70425365},{"date":"2023-10-04","current":-2.276024,"twenty":-3.782657,"median":-2.940605,"eighty":-2.474064,"marketCap":66405843},{"date":"2023-10-10","current":-2.098075,"twenty":-3.781281,"median":-2.875192,"eighty":-2.428715,"marketCap":61213961},{"date":"2023-10-19","current":-2.009101,"twenty":-3.779218,"median":-2.868708,"eighty":-2.413791,"marketCap":58618021},{"date":"2023-10-27","current":-1.922996,"twenty":-3.775091,"median":-2.867273,"eighty":-2.413791,"marketCap":56105820},{"date":"2023-11-03","current":-1.871334,"twenty":-3.740703,"median":-2.849368,"eighty":-2.290949,"marketCap":54598499},{"date":"2023-11-10","current":-1.690515,"twenty":-3.669177,"median":-2.844944,"eighty":-2.243878,"marketCap":49322877},{"date":"2023-11-17","current":-1.533738,"twenty":-3.658861,"median":-2.768921,"eighty":-2.084298,"marketCap":50453368},{"date":"2023-11-24","current":-1.527374,"twenty":-3.617595,"median":-2.739552,"eighty":-1.974659,"marketCap":50244018},{"date":"2023-12-01","current":-1.565558,"twenty":-3.614157,"median":-2.617571,"eighty":-1.90147,"marketCap":51500118},{"date":"2023-12-08","current":-1.48919,"twenty":-3.583895,"median":-2.583129,"eighty":-1.87076,"marketCap":48987917},{"date":"2023-12-15","current":-1.540102,"twenty":-3.452534,"median":-2.531467,"eighty":-1.708711,"marketCap":50662718},{"date":"2023-12-22","current":-1.476462,"twenty":-3.314983,"median":-2.474064,"eighty":-1.60527,"marketCap":48569217},{"date":"2023-12-29","current":-2.102685,"twenty":-3.232452,"median":-2.429577,"eighty":-1.641927,"marketCap":69169264},{"date":"2024-01-05","current":-2.03949,"twenty":-3.220072,"median":-2.413791,"eighty":-1.611379,"marketCap":67090423},{"date":"2024-01-12","current":-1.576818,"twenty":-3.100826,"median":-2.392265,"eighty":-1.585578,"marketCap":51870515},{"date":"2024-01-19","current":-1.427896,"twenty":-3.005423,"median":-2.30616,"eighty":-1.564031,"marketCap":46971633},{"date":"2024-01-26","current":-1.124213,"twenty":-2.973312,"median":-2.283466,"eighty":-1.540772,"marketCap":36981756},{"date":"2024-02-02","current":-1.314015,"twenty":-2.973312,"median":-2.260238,"eighty":-1.528392,"marketCap":43225429},{"date":"2024-02-09","current":-1.226414,"twenty":-2.973312,"median":-2.227231,"eighty":-1.508027,"marketCap":40343734},{"date":"2024-02-16","current":-1.220574,"twenty":-2.970933,"median":-2.10038,"eighty":-1.496317,"marketCap":40151621},{"date":"2024-02-23","current":-1.170933,"twenty":-2.967365,"median":-2.077039,"eighty":-1.484607,"marketCap":38518660},{"date":"2024-03-01","current":-1.185534,"twenty":-2.965581,"median":-2.037802,"eighty":-1.427936,"marketCap":38998943},{"date":"2024-03-08","current":-1.305255,"twenty":-2.958445,"median":-1.951697,"eighty":-1.350807,"marketCap":42937259},{"date":"2024-03-15","current":-1.530098,"twenty":-2.956661,"median":-1.917256,"eighty":-1.360152,"marketCap":50333611},{"date":"2024-03-22","current":-1.927222,"twenty":-2.947741,"median":-1.909363,"eighty":-1.380707,"marketCap":63397296},{"date":"2024-03-28","current":-2.178345,"twenty":-2.940605,"median":-1.925109,"eighty":-1.425549,"marketCap":71658156},{"date":"2024-04-05","current":-2.18389,"twenty":-2.875192,"median":-1.928736,"eighty":-1.427896,"marketCap":76862025},{"date":"2024-04-12","current":-2.872164,"twenty":-2.872164,"median":-2.000282,"eighty":-1.428095,"marketCap":101085828},{"date":"2024-04-19","current":-2.390082,"twenty":-2.870144,"median":-2.037802,"eighty":-1.436656,"marketCap":84118945},{"date":"2024-04-26","current":-2.64274,"twenty":-2.867273,"median":-2.070475,"eighty":-1.460017,"marketCap":93011227},{"date":"2024-05-03","current":-2.613699,"twenty":-2.860548,"median":-2.080854,"eighty":-1.476462,"marketCap":91989126},{"date":"2024-05-10","current":-2.758904,"twenty":-2.852923,"median":-2.121507,"eighty":-1.483377,"marketCap":97099633},{"date":"2024-05-17","current":-2.458726,"twenty":-2.860548,"median":-2.154849,"eighty":-1.484098,"marketCap":95873111},{"date":"2024-05-24","current":-2.3198,"twenty":-2.852923,"median":-2.20556,"eighty":-1.486644,"marketCap":90455973},{"date":"2024-05-31","current":-1.968554,"twenty":-2.850079,"median":-2.181118,"eighty":-1.488681,"marketCap":76759815},{"date":"2024-06-07","current":-2.125179,"twenty":-2.849368,"median":-2.152608,"eighty":-1.489212,"marketCap":82867106},{"date":"2024-06-14","current":-2.233016,"twenty":-2.846714,"median":-2.152608,"eighty":-1.492255,"marketCap":87071996},{"date":"2024-06-21","current":-1.741174,"twenty":-2.844944,"median":-2.140329,"eighty":-1.496317,"marketCap":67893594},{"date":"2024-06-28","current":-1.812189,"twenty":-2.844944,"median":-2.140329,"eighty":-1.498354,"marketCap":70662668},{"date":"2024-07-05","current":-0.967903,"twenty":-2.843237,"median":-2.110101,"eighty":-1.488172,"marketCap":37741454},{"date":"2024-07-12","current":-1.249432,"twenty":-2.834001,"median":-2.100781,"eighty":-1.469884,"marketCap":48719089},{"date":"2024-07-15","current":-1.260464,"twenty":-2.831302,"median":-2.098877,"eighty":-1.455345,"marketCap":49149280},{"date":"2024-08-02","current":-1.401267,"twenty":-2.828603,"median":-2.098877,"eighty":-1.436656,"marketCap":54639616},{"date":"2024-08-09","current":-1.290931,"twenty":-2.802466,"median":-2.080854,"eighty":-1.401267,"marketCap":50337284},{"date":"2024-08-16","current":-1.201045,"twenty":-2.796658,"median":-2.072003,"eighty":-1.349055,"marketCap":46438413},{"date":"2024-08-23","current":-1.241178,"twenty":-2.769689,"median":-2.062918,"eighty":-1.296495,"marketCap":47990130},{"date":"2024-08-30","current":-1.113164,"twenty":-2.768153,"median":-2.038646,"eighty":-1.281895,"marketCap":43040476},{"date":"2024-09-06","current":-1.110381,"twenty":-2.760754,"median":-2.011962,"eighty":-1.261256,"marketCap":42932874},{"date":"2024-09-13","current":-1.132616,"twenty":-2.753755,"median":-1.991463,"eighty":-1.24953,"marketCap":43792608},{"date":"2024-09-20","current":-1.430415,"twenty":-2.736707,"median":-1.971607,"eighty":-1.23844,"marketCap":55307011},{"date":"2024-09-27","current":-1.355277,"twenty":-2.727862,"median":-1.927222,"eighty":-1.247781,"marketCap":52401779},{"date":"2024-10-04","current":-1.35806,"twenty":-2.717602,"median":-1.920126,"eighty":-1.24953,"marketCap":52509380},{"date":"2024-10-11","current":-1.333014,"twenty":-2.703726,"median":-1.89225,"eighty":-1.251663,"marketCap":51540970},{"date":"2024-10-18","current":-1.327448,"twenty":-2.69392,"median":-1.871334,"eighty":-1.251663,"marketCap":51325767},{"date":"2024-10-25","current":-1.330231,"twenty":-2.68748,"median":-1.868821,"eighty":-1.256738,"marketCap":51433368},{"date":"2024-10-31","current":-1.15769,"twenty":-2.682816,"median":-1.860061,"eighty":-1.249543,"marketCap":44762095},{"date":"2024-11-08","current":-1.282921,"twenty":-2.678751,"median":-1.809791,"eighty":-1.251136,"marketCap":49604148},{"date":"2024-11-15","current":-1.251898,"twenty":-2.674104,"median":-1.720841,"eighty":-1.252073,"marketCap":58642648},{"date":"2024-11-22","current":-1.176095,"twenty":-2.654356,"median":-1.667384,"eighty":-1.249488,"marketCap":55091809},{"date":"2024-11-29","current":-1.171024,"twenty":-2.64274,"median":-1.629813,"eighty":-1.227353,"marketCap":54854273},{"date":"2024-12-06","current":-1.106606,"twenty":-2.639384,"median":-1.600178,"eighty":-1.22448,"marketCap":51836749},{"date":"2024-12-13","current":-1.148018,"twenty":-2.631897,"median":-1.571188,"eighty":-1.222594,"marketCap":53776586},{"date":"2024-12-20","current":-1.167573,"twenty":-2.62396,"median":-1.563013,"eighty":-1.217317,"marketCap":54692620},{"date":"2024-12-27","current":-1.166423,"twenty":-2.616797,"median":-1.547739,"eighty":-1.213926,"marketCap":54638735},{"date":"2025-01-03","current":-1.182527,"twenty":-2.613699,"median":-1.540102,"eighty":-1.211814,"marketCap":55393116},{"date":"2025-01-10","current":-1.304461,"twenty":-2.611376,"median":-1.530098,"eighty":-1.211814,"marketCap":61104858},{"date":"2025-01-17","current":-1.48161,"twenty":-2.609328,"median":-1.528647,"eighty":-1.213041,"marketCap":69403049},{"date":"2025-01-24","current":-1.656458,"twenty":-2.608318,"median":-1.528647,"eighty":-1.213574,"marketCap":77593471},{"date":"2025-01-31","current":-2.167199,"twenty":-2.60789,"median":-1.530098,"eighty":-1.21433,"marketCap":101518124},{"date":"2025-02-07","current":-2.162598,"twenty":-2.593884,"median":-1.54094,"eighty":-1.214734,"marketCap":101302587},{"date":"2025-02-14","current":-1.769189,"twenty":-2.583696,"median":-1.557921,"eighty":-1.214981,"marketCap":82874137},{"date":"2025-02-21","current":-1.863515,"twenty":-2.577932,"median":-1.565558,"eighty":-1.217317,"marketCap":87292655},{"date":"2025-02-28","current":-1.902626,"twenty":-2.570137,"median":-1.584118,"eighty":-1.220574,"marketCap":89124723},{"date":"2025-03-07","current":-1.833607,"twenty":-2.564329,"median":-1.603098,"eighty":-1.220574,"marketCap":85891661},{"date":"2025-03-14","current":-2.672649,"twenty":-2.570137,"median":-1.649192,"eighty":-1.221023,"marketCap":125194918},{"date":"2025-03-21","current":-2.747078,"twenty":-2.60789,"median":-1.669929,"eighty":-1.222594,"marketCap":128681358},{"date":"2025-03-28","current":-2.594838,"twenty":-2.612537,"median":-1.719708,"eighty":-1.224155,"marketCap":121550002},{"date":"2025-04-04","current":-1.679468,"twenty":-2.612537,"median":-1.718575,"eighty":-1.22448,"marketCap":87161019},{"date":"2025-04-11","current":-1.557114,"twenty":-2.610061,"median":-1.684991,"eighty":-1.225254,"marketCap":80811079},{"date":"2025-04-17","current":-1.492618,"twenty":-2.608747,"median":-1.667384,"eighty":-1.226414,"marketCap":77463875},{"date":"2025-04-25","current":-1.557114,"twenty":-2.60789,"median":-1.641927,"eighty":-1.226584,"marketCap":80811079},{"date":"2025-05-02","current":-1.541757,"twenty":-2.60528,"median":-1.62119,"eighty":-1.227308,"marketCap":80014126},{"date":"2025-05-09","current":-1.710675,"twenty":-2.59278,"median":-1.624681,"eighty":-1.230226,"marketCap":88780614},{"date":"2025-05-16","current":-1.653585,"twenty":-2.584263,"median":-1.647756,"eighty":-1.242829,"marketCap":84795847},{"date":"2025-05-23","current":-1.600745,"twenty":-2.580531,"median":-1.656458,"eighty":-1.249451,"marketCap":82086205},{"date":"2025-05-30","current":-2.337537,"twenty":-2.570137,"median":-1.661535,"eighty":-1.249526,"marketCap":119868907},{"date":"2025-06-06","current":-2.328187,"twenty":-2.570137,"median":-1.667973,"eighty":-1.249555,"marketCap":119389431},{"date":"2025-06-13","current":-2.499606,"twenty":-2.555617,"median":-1.681559,"eighty":-1.251898,"marketCap":128179818},{"date":"2025-06-20","current":-2.480906,"twenty":-2.548647,"median":-1.689176,"eighty":-1.252132,"marketCap":127220867},{"date":"2025-06-27","current":-2.462206,"twenty":-2.546034,"median":-1.702427,"eighty":-1.256738,"marketCap":126261915},{"date":"2025-07-03","current":-2.465323,"twenty":-2.537207,"median":-1.714625,"eighty":-1.258423,"marketCap":126421741},{"date":"2025-07-11","current":-2.577524,"twenty":-2.561425,"median":-1.730079,"eighty":-1.259794,"marketCap":132175448},{"date":"2025-07-18","current":-2.898546,"twenty":-2.579766,"median":-1.757979,"eighty":-1.261058,"marketCap":148637445},{"date":"2025-07-25","current":-3.057499,"twenty":-2.600059,"median":-1.764061,"eighty":-1.263206,"marketCap":156788531},{"date":"2025-08-01","current":-3.057499,"twenty":-2.611957,"median":-1.792196,"eighty":-1.270493,"marketCap":156788531},{"date":"2025-08-08","current":-2.826862,"twenty":-2.625853,"median":-1.812189,"eighty":-1.274572,"marketCap":144961465},{"date":"2025-08-15","current":-2.971121,"twenty":-2.638357,"median":-1.82441,"eighty":-1.276242,"marketCap":162258860},{"date":"2025-08-22","current":-3.41649,"twenty":-2.660123,"median":-1.836892,"eighty":-1.279025,"marketCap":186581365},{"date":"2025-08-29","current":-3.090683,"twenty":-2.678751,"median":-1.856037,"eighty":-1.280138,"marketCap":168788391},{"date":"2025-09-05","current":-3.243125,"twenty":-2.691143,"median":-1.861215,"eighty":-1.280841,"marketCap":177113544},{"date":"2025-09-12","current":-3.461326,"twenty":-2.704217,"median":-1.868463,"eighty":-1.282305,"marketCap":189029939},{"date":"2025-09-19","current":-3.426952,"twenty":-2.741354,"median":-1.870693,"eighty":-1.282921,"marketCap":187152699},{"date":"2025-09-26","current":-3.243125,"twenty":-2.769075,"median":-1.877319,"eighty":-1.282921,"marketCap":177113544},{"date":"2025-10-03","current":-3.308884,"twenty":-2.807845,"median":-1.880771,"eighty":-1.283679,"marketCap":180704787},{"date":"2025-10-10","current":-3.302906,"twenty":-2.827907,"median":-1.893424,"eighty":-1.284815,"marketCap":180378310},{"date":"2025-10-17","current":-3.004001,"twenty":-2.847185,"median":-1.902048,"eighty":-1.285226,"marketCap":164054481},{"date":"2025-10-24","current":-2.839603,"twenty":-2.847185,"median":-1.911829,"eighty":-1.285928,"marketCap":155076375},{"date":"2025-10-31","current":-2.764876,"twenty":-2.849368,"median":-1.920126,"eighty":-1.286056,"marketCap":150995418},{"date":"2025-11-07","current":-2.711073,"twenty":-2.849092,"median":-1.927222,"eighty":-1.288006,"marketCap":148057129},{"date":"2025-11-14","current":-2.723029,"twenty":-2.847185,"median":-1.960142,"eighty":-1.291742,"marketCap":148710082},{"date":"2025-11-21","current":-3.044807,"twenty":-2.852183,"median":-1.968554,"eighty":-1.293396,"marketCap":139625737},{"date":"2025-11-28","current":-3.566883,"twenty":-2.866671,"median":-1.979039,"eighty":-1.294541,"marketCap":163566570},{"date":"2025-12-05","current":-3.172468,"twenty":-2.874818,"median":-2.003244,"eighty":-1.298088,"marketCap":145479882},{"date":"2025-12-12","current":-3.189617,"twenty":-2.895724,"median":-2.026861,"eighty":-1.30462,"marketCap":146266260},{"date":"2025-12-19","current":-3.044807,"twenty":-2.909766,"median":-2.045829,"eighty":-1.306911,"marketCap":139625737},{"date":"2025-12-26","current":-3.121023,"twenty":-2.940605,"median":-2.061171,"eighty":-1.313533,"marketCap":143120749},{"date":"2026-01-02","current":-3.033375,"twenty":-2.951309,"median":-2.069254,"eighty":-1.313919,"marketCap":139101485},{"date":"2026-01-09","current":-3.140077,"twenty":-2.967365,"median":-2.073224,"eighty":-1.319745,"marketCap":143994502},{"date":"2026-01-16","current":-2.976214,"twenty":-2.971559,"median":-2.091032,"eighty":-1.321741,"marketCap":136480226},{"date":"2026-01-23","current":-3.052429,"twenty":-2.973312,"median":-2.098877,"eighty":-1.323552,"marketCap":139975238},{"date":"2026-01-30","current":-3.079104,"twenty":-2.996791,"median":-2.104138,"eighty":-1.326335,"marketCap":141198492},{"date":"2026-02-06","current":-2.899998,"twenty":-3.001047,"median":-2.123183,"eighty":-1.329118,"marketCap":132985214},{"date":"2026-02-13","current":-3.20486,"twenty":-3.016702,"median":-2.141892,"eighty":-1.330231,"marketCap":146965263},{"date":"2026-02-20","current":-3.376345,"twenty":-3.028471,"median":-2.152608,"eighty":-1.330231,"marketCap":154829040},{"date":"2026-02-27","current":-4.473847,"twenty":-3.047094,"median":-2.164899,"eighty":-1.331344,"marketCap":205157216},{"date":"2026-03-06","current":-4.504333,"twenty":-3.057499,"median":-2.178345,"eighty":-1.333556,"marketCap":206555221},{"date":"2026-03-13","current":-4.153742,"twenty":-3.067672,"median":-2.211139,"eighty":-1.339393,"marketCap":190478164},{"date":"2026-03-20","current":-5.569355,"twenty":-3.075294,"median":-2.233016,"eighty":-1.347426,"marketCap":220384966},{"date":"2026-03-27","current":-5.030086,"twenty":-3.082722,"median":-2.237299,"eighty":-1.348526,"marketCap":199045520},{"date":"2026-04-02","current":-4.955704,"twenty":-3.086726,"median":-2.253224,"eighty":-1.350299,"marketCap":196102148},{"date":"2026-04-10","current":-4.783695,"twenty":-3.093606,"median":-2.276024,"eighty":-1.355785,"marketCap":189295601},{"date":"2026-04-17","current":-5.857586,"twenty":-3.105152,"median":-2.29181,"eighty":-1.357865,"marketCap":231790532},{"date":"2026-04-24","current":-5.50892,"twenty":-3.121023,"median":-2.3198,"eighty":-1.360347,"marketCap":217993476},{"date":"2026-05-01","current":-4.937108,"twenty":-3.143126,"median":-2.325304,"eighty":-1.369992,"marketCap":195366305},{"date":"2026-05-08","current":-4.653527,"twenty":-3.147846,"median":-2.361395,"eighty":-1.372531,"marketCap":184144700},{"date":"2026-05-15","current":-4.989852,"twenty":-3.167307,"median":-2.38041,"eighty":-1.376983,"marketCap":200517206},{"date":"2026-05-22","current":-4.532067,"twenty":-3.181169,"median":-2.40143,"eighty":-1.386168,"marketCap":182121132},{"date":"2026-05-29","current":-4.857095,"twenty":-3.20486,"median":-2.406105,"eighty":-1.387284,"marketCap":195182345},{"date":"2026-06-05","current":-6.376939,"twenty":-3.220103,"median":-2.413791,"eighty":-1.391455,"marketCap":256257310},{"date":"2026-06-12","current":-6.381517,"twenty":-3.240136,"median":-2.425271,"eighty":-1.394238,"marketCap":256441271},{"date":"2026-06-18","current":-2.156165,"twenty":-3.240734,"median":-2.415455,"eighty":-1.393681,"marketCap":86645508},{"date":"2026-06-26","current":-1.779734,"twenty":-3.235354,"median":-2.413791,"eighty":-1.395448,"marketCap":71518597},{"date":"2026-07-02","current":-2.439422,"twenty":-3.233134,"median":-2.409948,"eighty":-1.396192,"marketCap":98028157},{"date":"2026-07-10","current":-1.656339,"twenty":-3.228095,"median":-2.40143,"eighty":-1.396192,"marketCap":66559974},{"date":"2026-07-17","current":-1.518706,"twenty":-3.222138,"median":-2.38041,"eighty":-1.398476,"marketCap":61029203},{"date":"2026-07-24","current":-1.838338,"twenty":-3.220103,"median":-2.361395,"eighty":-1.400681,"marketCap":73873607},{"date":"2026-07-31","current":-1.698274,"twenty":-3.217817,"median":-2.328187,"eighty":-1.401795,"marketCap":68245142},{"date":"2026-08-07","current":-1.832502,"twenty":-3.21336,"median":-2.321111,"eighty":-1.403699,"marketCap":73639088},{"date":"2026-08-14","current":-2.06017,"twenty":-3.209035,"median":-2.293245,"eighty":-1.405369,"marketCap":82787928},{"date":"2026-08-21","current":-2.135694,"twenty":-3.203336,"median":-2.279745,"eighty":-1.406482,"marketCap":80816787},{"date":"2026-08-28","current":-2.083604,"twenty":-3.196476,"median":-2.253386,"eighty":-1.408152,"marketCap":78845646},{"date":"2026-09-04","current":-1.736336,"twenty":-3.187108,"median":-2.237299,"eighty":-1.409007,"marketCap":65704705},{"date":"2026-09-11","current":-1.465468,"twenty":-3.181169,"median":-2.233016,"eighty":-1.410419,"marketCap":55454771},{"date":"2026-09-18","current":-1.295307,"twenty":-3.172087,"median":-2.217813,"eighty":-1.405926,"marketCap":49015709},{"date":"2026-09-25","current":-1.305725,"twenty":-3.17013,"median":-2.181118,"eighty":-1.400096,"marketCap":49409938},{"date":"2026-10-01","current":-1.264053,"twenty":-3.168399,"median":-2.173997,"eighty":-1.394238,"marketCap":47833025}],"updateTime":1790964462269},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644456307","title":"Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2644456307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644456307?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644455297","title":"Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644455297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644455297?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644276007","title":"SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2644276007","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644276007?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642662,"startTime":"0","endTime":"0","summary":"SueWallSt opened a securities investigation into Elicio Therapeutics tied to disclosures on its ELI-002 7P pancreatic cancer program.Shares fell 72.53% in one session following release of Phase 2 AMPLIFY-7P results that missed the primary disease-free survival endpoint.The probe focuses on whether prior statements on ELI-002 7P prospects or the AMPLIFY-7P program were materially misleading.The alert cited a June 9 Q1 2026 filing showing zero revenue and a widening net loss driven by higher R&D spending.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4Pybgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644769122","title":"Elicio Therapeutics Cut to Hold From Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2644769122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644769122?lang=en_us&edition=fundamental","pubTime":"2026-06-17 00:38","pubTimestamp":1781627880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 12:38 ET (16:38 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643120785","title":"Elicio Therapeutics downgraded to Hold from Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2643120785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643120785?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:11","pubTimestamp":1781554298,"startTime":"0","endTime":"0","summary":"JonesResearch downgraded Elicio Therapeutics (ELTX) to Hold from Buy without a price target The company’s Phase IIb trial failed to show a signific...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643019200","title":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2643019200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643019200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:13","pubTimestamp":1781547236,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, PaychexWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL6N42N0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","ELTX","XOMO","FCX","LUV","MRAL","SCCO","RCL","COII","SNK","SHAZ","MUU","ABNB","PSKY","PTRN","CONY","HUT","RIOT","XOMX","MU","COIW","LXEO","AAL","FOXA","OXY","NCLH","CMTL","TRIP","SPCX","COYY","NMRA","ABNY","CVX","MARA","UAL","LCLN","ICOI","COIN","NEM","CCL","SPCU","XOM","DAL","BAND","DDOG","APA","FISV","CONI","PTCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241200","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643241200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:01","pubTimestamp":1781546505,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  said Monday its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p failed to meet the pre-specified primary endpoint of disease-free survival.Shares sank 72% after a surge in intraday trading volume to over 7.10 million from a daily average of about 131,000.Comtech Telecommunications  agreed to sell most of its Satellite and Space Communications segment to Gilat Satellite Networks  for $157.5 million, the companies said in separate statements Monday.Shares of Comtech Telecommunications plummeted 43% as intraday trading volume climbed to more than 3.72 million, versus a daily average of about 297,000.Fox  agreed to acquire Roku  in a cash-and-stock deal that values the TV streaming platform at about $22 billion, creating a media and technology entity with one of the largest streaming businesses in the US.Fox shares dropped 16%, with intraday trading volume rising to more than 4.48 million from the stock's daily average of about 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4507","ROKU","IE00B7SZL793.SGD","BK4020","FOX","BK4139","BK4108","IE0031619046.USD","ELTX","BK4588","CMTL","LU1861558580.USD","IE00B66KJ199.SGD","BK4585","IE00B19Z4B17.USD","LU1169590202.USD","BK4548","BK4524","FOXA","BK4007","LU0963586101.USD","BK4125","GILT","BK4532","LU1169589451.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643414209","title":"Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2643414209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643414209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:56","pubTimestamp":1781531805,"startTime":"0","endTime":"0","summary":"Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goalJune 15 (Reuters) - Elicio Therapeutics ELTX.O shares fell about 73% in early trading on Monday after the biotech firm's","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N11B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643209228","title":"Elicio selloff brings attractive entry point, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2643209228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643209228?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:50","pubTimestamp":1781531427,"startTime":"0","endTime":"0","summary":"H.C. Wainwright views the selloff today in shares of Elicio Therapeutics (ELTX) as an attractive entry point for investors. The company presented f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-selloff-brings-attractive-entry-point-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-selloff-brings-attractive-entry-point-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643092852","title":"Elicio Unveils Phase 2 ELI-002 Results and Phase 3 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2643092852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643092852?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:49","pubTimestamp":1781531391,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics ( ($ELTX) ) has provided an update. On June 15, 2026, Elicio Therapeutics reported topline results from its randomized Phase 2 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elicio-unveils-phase-2-eli-002-results-and-phase-3-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elicio-unveils-phase-2-eli-002-results-and-phase-3-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643030252","title":"Elicio Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2643030252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643030252?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:28","pubTimestamp":1781526480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 15, 2026 08:28 ET (12:28 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203469","title":"Elicio Therapeutics Shares Fall After Missing Primary Endpoint in Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203469","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203469?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:19","pubTimestamp":1781525983,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  shares were down by more than 50% in Monday's premarket activity after it said its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p did not meet the pre-specified primary endpoint of disease-free survival.An imbalance in patient randomization placed more individuals with a higher risk of relapse into the active treatment group, which negatively impacted the overall trial outcome, the company said.Post-hoc analyses of secondary endpoints revealed the drug provided a measurable survival benefit for a specific subset of trial participants possessing lower residual disease, Elicio Therapeutics said.The company intends to design its Phase 3 trial exclusively around this lower-risk demographic while administering additional doses, it said.Elicio anticipates current cash will sustain operations into Q4 as it seeks strategic funding options to advance the clinical program, the company added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643720317","title":"Elicio Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $23 From $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2643720317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643720317?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:17","pubTimestamp":1781525853,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAZN4T2CV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643039102","title":"Elicio Therapeutics Shares Fall 50% Premarket After Co Reports Mid-Stage Data for Its Experimental Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2643039102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643039102?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:13","pubTimestamp":1781525606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N13C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203525","title":"BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203525","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203525?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:08","pubTimestamp":1781525283,"startTime":"0","endTime":"0","summary":"BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial** Shares of biotech firm Elicio Therapeutics ELTX.O fall 50% to $7.43 premarket** Company says its experimental vaccine, ELI-002 7P, being tested in pancreatic cancer patients failed to prevent the return of the disease    ** ELTX says mid-stage study tested 144 patients after surgery and standard treatment** Says subgroup with fully removed tumors saw 35% lower risk of cancer returning** Pancreatic cancer is hard to treat as it is often diagnosed late and responds poorly to existing therapies    ** Company says vaccine triggered immune response linked to better outcomes** Plans late-stage study focused on subgroup and longer treatment - ELTX** As of last close, stock up ~87% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270305","title":"Elicio says Phase 2 AMPLIFY-7P trial of ELI-002 7P misses primary DFS endpoint in adjuvant pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270305?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521223,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics reported Phase 2 AMPLIFY-7P results for ELI-002 7P in adjuvant mKRAS-driven pancreatic cancer; results were presented today.The study missed its main disease-free survival goal in the overall population, weighing on the near-term registrational path.Post-hoc analyses indicated a clearer benefit in patients with complete tumor removal, supporting a narrower target population for late-stage development.Immune-response findings aligned with better clinical outcomes, reinforcing the drug’s biological activity despite the primary endpoint miss.Planning shifted to a Phase 3 program focused on completely resected patients with longer dosing; execution depends on financing or partnering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDLbjbZ7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","IE00BN0W2W23.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","BK4588","LU2210149790.SGD","ELTX","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643705372","title":"Elicio Therapeutics - Eli-2 7P Demonstrates Favorable Safety and Tolerability Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2643705372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643705372?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643703112","title":"Elicio Therapeutics Reports Results From Phase 2 Amplify-7P Study and Outlines Refined Phase 3 Development Strategy for Eli-002 7P in Adjuvant Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643703112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643703112?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643427058","title":"Elicio Therapeutics - Evaluating Strategic Financing and Partnering Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2643427058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643427058?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270582","title":"Elicio Therapeutics - to Focus Phase 3 Development on R0 Resected Population With Additional Eli-2 7P Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270582?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}]}}